Warning: The NCBI web site requires JavaScript to function. more...
Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study.
Birth M, Figueras J, Bernardini S, Troen T, Günther K, Mirza D, Mortensen FV.
Patient Saf Surg. 2009 Jun 22;3(1):13.
Related citations
TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial.
Maisano F, Kjaergård HK, Bauernschmitt R, Pavie A, Rábago G, Laskar M, Marstein JP, Falk V.
Eur J Cardiothorac Surg. 2009 Oct;36(4):708-14.
Fibrin sealant (evicel® [quixil®/crosseal™]): a review of its use as supportive treatment for haemostasis in surgery.
Dhillon S.
Drugs. 2011 Oct 1;71(14):1893-915. doi: 10.2165/11207700-000000000-00000. Review.
Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial.
Frilling A, Stavrou GA, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, Thörne A, Gloor B, Beckebaum S, Ghaffar MF, Broelsch CE.
Langenbecks Arch Surg. 2005 Apr;390(2):114-20. Epub 2005 Feb 19.
A single arm, prospective study of an absorbable cyanoacrylate surgical sealant for use in vascular reconstructions as an adjunct to conventional techniques to achieve haemostasis.
Brunkwall J, Ruemenapf G, Florek HJ, Lang W, Schmitz-Rixen T.
J Cardiovasc Surg (Torino). 2007 Aug;48(4):471-6.
Fibrin sealant: a review of its use in surgery and endoscopy.
Dunn CJ, Goa KL.
Drugs. 1999 Nov;58(5):863-86. Review.
Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study.
Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J, et al.
J Thorac Cardiovasc Surg. 1989 Feb;97(2):194-203.
Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin sealant: multicentre, randomized, controlled, clinical trial.
Cardillo G, Carleo F, Carbone L, De Massimi AR, Lococo A, Santini PF, Janni A, Gonfiotti A.
Eur J Cardiothorac Surg. 2011 Dec 16. [Epub ahead of print]
A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI, Gómez-Outes A, Martínez-González J, Rocha E; Bemiparin 6 Hours After Surgery Study Group.
Arch Orthop Trauma Surg. 2007 Oct;127(8):665-70. Epub 2006 Nov 7.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
[Venous thromboembolism prophylaxis after total hip arthroplasty].
Kučera T, Malý R, Urban K, Sponer P.
Acta Chir Orthop Traumatol Cech. 2011;78(2):101-5. Czech.
A Randomized Trial of Aprotinin-Free Fibrin Sealant Versus Absorbable Hemostat.
Fischer CP, Wood CG, Shen J, Batiller J, Hart JC, Patel B, Albala DM.
Clin Appl Thromb Hemost. 2011 Aug 25. [Epub ahead of print]
Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial.
Codispoti M, Mankad PS.
Eur J Cardiothorac Surg. 2002 Aug;22(2):200-5.
Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Colonna JO 2nd, Heaton N, Mirza D, Adams R, Rees M, Lloyd D.
Arch Surg. 2004 Nov;139(11):1148-54.
Sellar repair with fibrin sealant and collagen fleece after endoscopic endonasal transsphenoidal surgery.
Cappabianca P, Cavallo LM, Valente V, Romano I, D'Enza AI, Esposito F, de Divitiis E.
Surg Neurol. 2004 Sep;62(3):227-33; discussion 233.
A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.
J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.
The measurement and monitoring of surgical adverse events.
Bruce J, Russell EM, Mollison J, Krukowski ZH.
Health Technol Assess. 2001;5(22):1-194. Review.
Autologous fibrin sealant reduces pain after tonsillectomy.
Gross CW, Gallagher R, Schlosser RJ, Burks SG, Flanagan HL, Mintz PD, Avery NL, Mayers SL, Spotnitz WD.
Laryngoscope. 2001 Feb;111(2):259-63.
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ.
BMJ. 2007 Mar 31;334(7595):674. Epub 2007 Feb 8.
Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.
Crinò L, Dansin E, Garrido P, Griesinger F, Laskin J, Pavlakis N, Stroiakovski D, Thatcher N, Tsai CM, Wu YL, Zhou C.
Lancet Oncol. 2010 Aug;11(8):733-40. Epub 2010 Jul 23.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on